Peptidylarginine deiminases (PAD) catalyze the conversion of arginine residues to citrullines. Five isoforms are known that present distinct tissue locations. In the epidermis, like in the skin, only PAD1, 2, and 3 are expressed. Their pattern of expression in skin appendages is not known. Here, confocal microscopy analysis using highly specific antibodies demonstrated that PAD1 and 3 are expressed in human anagen hair follicles, PAD1 and 2, in arrector pili muscles and sweat glands, whereas no PAD were detected in sebaceous glands. PAD1 was detected in the cuticle and the Huxley layer of the inner root sheath (IRS), and in the companion layer. PAD3 was localized in the medulla, and in the three layers of the IRS. Using anti-modified citrulline antibodies, we also showed that deiminated proteins appeared in the lower part of the IRS, first in the Henle layer, then in the cuticle, and finally in the Huxley layer. Our data demonstrate that PAD3 is the enzyme that deiminates trichohyalin in the medulla and the Henle layer, indicate that PAD1 and 3 are involved in the hair follicle program of differentiation, and suggest a role for PAD1 and 2 in the physiology of sweat glands and arrector pili muscles.
The peptidylarginine deiminase (PAD) enzymes (proteinarginine deiminase, protein-L-arginine iminohydrolase, EC 3.5.3.15) are responsible for the formation of protein-bound citrulline in the presence of calcium ions. First detected in the hair follicles of the guinea-pig (Rogers and Taylor, 1977) , PAD activity has been identified in various tissues of almost all vertebrates (for a review, see Vossenaar et al, 2003) . Five human PAD genes, clustered on chromosome 1p35-36, have been described and named PADI1, 2, 3, 4, and 6 on the basis of their cDNA nucleotide sequence and of the in vitro biochemical features of their products: the PAD1, 2, 3, 4 (formerly named PAD type 5), and 6 (Nakashima et al, 1999; Rus'd et al, 1999; Kanno et al, 2000; Ishigami et al, 2002; Guerrin et al, 2003; Chavanas et al, 2004) . PAD1 is mainly found in the epidermis and uterus (Terakawa et al, 1991; Rus'd et al, 1999; Guerrin et al, 2003; Nachat et al, 2005) . PAD2 is widely expressed in various tissues including skeletal muscle, brain, uterus, salivary glands, pancreas, and epidermis (Kubilus and Baden, 1985; Takahara et al, 1989; Watanabe and Senshu, 1989; Akiyama et al, 1990; Terakawa et al, 1991; Ishigami et al, 2002; Nachat et al, 2005) . PAD3 is expressed in the epidermis and hair follicles (Terakawa et al, 1991; Rogers et al, 1997; Rus'd et al, 1999; Kanno et al, 2000; Nachat et al, 2005) . PAD4 is found in hematopoietic cells (Nakashima et al, 1999; Asaga et al, 2001; Vossenaar et al, 2004) . Human PAD6 mRNA were mainly detected in ovary, peripheral blood leukocytes, and testis (Chavanas et al, 2004) . The structure of PAD4 determined after crystallization shows two elongated domains, each with at least two calcium-binding sites. Calcium-binding induces conformational changes that generate the active site cleft, formed by five b-strands. Moreover, PAD4 was shown to form a head-to-tail dimer (Arita et al, 2004) .
Little is known about the exact functions and substrates of PAD. Deimination dramatically alters the charge of arginine residues from positive to neutral and results in the unfolding of target proteins. Recently, the deimination of histones by PAD4 was described as a novel mechanism for antagonizing the transcription induction mediated by arginine methylation (Cuthbert et al, 2004; Wang et al, 2004) .
This post-translational modification has been implicated in the pathogenesis of multiple sclerosis and rheumatoid arthritis. Indeed, increased deimination of myelin basic protein and glial fibrillary acidic protein has been observed in the brain of multiple sclerosis patients (Kim et al, 2003; Nicholas et al, 2004) . In rheumatoid arthritis, deiminated forms of fibrin deposited in the rheumatoid synovial membranes are the major target of disease-specific autoantibodies (Masson-Bessiè re et al, 2001) . In a Japanese population, PADI4 gene polymorphisms were strongly linked to susceptibility to the rheumatic disease (Suzuki et al, 2003) . Moreover, a recent study revealed that PAD can act as an autoantigen in patients with various inflammatory rheumatic diseases (Nissinen et al, 2003) .
In normal epidermis, where keratin K1 was identified as the major deiminated epidermal protein, K10 and filaggrin as the minor ones, the deiminated proteins are located in the cornified layers, suggesting a role for PAD during the terminal stages of epidermal differentiation (Senshu et al, 1995; Senshu et al, 1996) . Deimination of filaggrin induces its disassembly from keratin intermediate filaments, and probably facilitates its proteolysis. This degradation generates a pool of amino acids that contribute to the cutaneous natural moisturizing factor (Rawlings and Harding, 2004) . Alterations in the pattern of deiminated proteins in human epidermis have been reported in some skin disorders, namely psoriasis and bullous congenital ichthyosiform erythroderma (Ishida-Yamamoto et al, 2000 .
In the hair follicles (HF), trichohyalin (THH), a high molecular weight structural a-helix-rich protein of the inner root sheath (IRS) and the medulla, is deiminated by PAD (Rogers and Taylor, 1977) . The following model of THH processing, including its deimination, has been proposed. First, THH is synthesized in the IRS keratinocytes as a large insoluble protein-forming cytoplasmic granules. Then, deimination of THH at the periphery of the granules generates a more soluble form that is released and intermixed with keratin intermediate filaments. THH is subsequently cross-linked by transglutaminase 3 to itself and to keratins (Tarcsa et al, 1997; Steinert et al, 2003) . In the medulla, which contains few if any keratin intermediate filaments, the disperse THH seems to be cross-linked as vacuolated aggregates entrapping air. But, the PAD isoforms used for THH deimination are unknown. Until now, only PAD3 has been detected in HF. In situ hybridization and double immunofluorescence (IF) staining revealed its co-expression with THH in wool follicles of sheep and in human HF, respectively (Rogers et al, 1997; Kanno et al, 2000) . By RT-PCR experiments, we recently demonstrated that three PADI genes are expressed in human skin, i.e., PADI1, 2, and 3. Accordingly, using antibodies highly specific for each PAD, we showed that PAD1, 2, and 3 are actually expressed in the epidermis. These results suggested that PAD other than PAD3 may be expressed in HF. Here, we investigated the pattern of expression of these PAD in the human anagen HF and in other skin appendages.
Results
By RT-PCR experiments, we previously demonstrated that PADI1, 2, and 3 are the only PAD genes expressed in the skin. In this study, we analyzed the expression of these three PAD in human HF and skin appendages by indirect IF and confocal microscopy using specific affinity purified anti-peptide antibodies. Anagen HF were not stained with the anti-PAD2(C 2 ) antibodies (data not shown), but showed clear expression of PAD1 and 3.
Localization of PAD1 in anagen HF Several distinct concentric compartments compose the HF: the outer root sheath (ORS), which is the outermost layer, the IRS, and the central hair shaft itself. The ORS and IRS are separated by the companion layer. Three subcompartments further composed the IRS: the Henle and Huxley layers, and the cuticle in direct contact with the cuticle of the hair shaft. To precisely localize PAD1 in the different layers of the HF, we performed double-label IF staining using the anti-PAD1 antibodies and two monoclonal antobodies (MoAb) directed to either the desmosomal cadherins DSG1 and DSG2 (DG3.10) or to corneodesmosin (CDSN), a corneodesmosomal protein (G36-19). DG3.10 labeled the IRS from the stem cells to the keratogenous zone, and part of the hair shaft (Fig 1A-C , see also Fig 2A-D) . As described (Mils et al, 1992) , G36-19 also stained the IRS, but the labeling appeared first (from the base of the HF) in the Henle layer, then in the IRS cuticle, and finally in the Huxley layer. It persisted in the three layers up to the isthmus (Fig 1D, see also Fig 3A) .
PAD1 was detected first in the IRS cuticle at the height of the dermal papilla, then in the Huxley layer ( Fig 1A and C) , and finally, in the middle portion of the HF, in the companion layer ( Fig 1B) . PAD1 persisted in the cornified Huxley layer, characterized by the abrupt disappearance of DG3.10 staining (Fig 1A and B) . Double-label IF staining using anti-PAD1 and G36-19 antibodies on transversal sections (Fig 1D-F) revealed that in the upper portion of the HF, PAD1 was restricted to the companion layer. PAD1 expression was also observed in cells of the Huxley layer that developed pseudopodal extensions passing through the cornified Henle layer (Fig 1A, triangle) . These cells probably correspond to the specialized so-called Flu¨gelzellen cells (Langbein et al, 2003) . In every case, the labeling produced by the anti-PAD1 was cytoplasmic.
Localization of PAD3 in anagen HF We performed double-label IF staining using the anti-PAD3(B 3 ) antibodies and the MoAb DG3.10, G36-19, and AE16. AE16 is known to label the THH granules of the IRS and the medulla of the HF but not to react with THH when it is associated with the IRS filaments (O'Guin et al, 1992) . Double-label IF using the anti-PAD3(B 3 ) and DG3.10 antibodies revealed cytoplasmic expression of PAD3 in the Henle and Huxley layers and in the cuticle of the IRS, in the bulb region (Fig 2A and B) . Then, the labeling of the Henle layer abruptly disappeared, as observed on longitudinal (Fig 2A) and transversal ( Fig 2C) sections of HF. Finally, PAD3 was no longer detected in the cornified Huxley layer characterized by the disappearance of DG3.10 staining (Fig 2A and D) . A higher magnification showed that the labeling in the Huxley layer was granular. In some cases, only the periphery of the granules seemed to be stained (Fig 2E, arrows) . Fig 2A, G, and F show that PAD3 is also expressed in the Flu¨gelzellen cells and in the medulla, respectively. Double-label IF staining on longitudinal and transversal sections of HF, using the anti-PAD3(B 3 ) and G36-19, antibodies showed that the loss of PAD3 detection in the IRS coincided with the appearance of CDSN expression, first in the Henle layer (Fig 3A and C) , then in the cuticle, and finally in the Huxley layer (Fig 3A and D) . Therefore, disappearance of anti-PAD3(B 3 ) staining corresponded to the asynchronous onset of abrupt cornification of these three layers.
Double-label IF staining on tangential sections of HF, using the anti-PAD3(B 3 ) and AE16 antibodies, showed that the onset of AE16 labeling nearly coincided with the disappearance of PAD3 detection (Fig 4A-C) . AE16 labeling appeared abruptly in distinct cells, and then rapidly became diffuse before its total disappearance (Fig 4B) . This corresponds to the dispersion of THH granules and the association of THH with the IRS filaments (Rothnagel and Rogers, et al, 1992) . In some cells, the anti-PAD3(B 3 ) and AE16 labelings were co-localized (Fig 4C) .
1986; O'Guin
Localization of PAD in other skin appendages: sweat glands, sebaceous glands, and hair arrector pili muscles Analysis of human scalp sections by indirect IF with the anti-PAD antibodies showed the presence of PAD1 and PAD2 but not of PAD3 in sweat glands or in the arrector pili muscles, whereas no immunoreactivities were detected in sebaceous glands (data not shown). We then performed double-label IF staining using either the anti-PAD1 or anti-PAD2(C 2 ) antibodies and a MoAb specific to smooth muscle a-actin (Figs 5 and 6 ). Both PAD1 and PAD2 were observed to co-localize with a-actin in the arrector pili muscles (Fig 5A-C and D-F, respectively) and in the myoepithelial cells at the periphery of the sweat glands (Fig 6A-C and  D-F, respectively) . Staining of the cytoplasm of the secretory cells of sweat glands was also observed with the anti-PAD1 and anti-PAD2(C 2 ) antibodies (Fig 6A, C, D, and F) .
Localization of deiminated proteins in anagen HF To determine whether the presence of PAD in skin appendages was associated with deimination of proteins, we performed immunohistochemistry analyses using AMC, purified antibodies specific to chemically modified citrullines, as previously published (Senshu et al, 1995) . On longitudinal sections of HF, AMC labeling appeared in the lower part of the IRS, first in the Henle layer (Fig 7A) , then in the IRS cuticle, and finally in the Huxley layer (Fig 7B and C) . The labeling persisted in the IRS at the isthmus. The medulla was also strongly labeled (Fig 7C) . The detection of deiminated proteins coincided with the asynchronous onset of abrupt cornification of the IRS Henle layer, cuticle, and Huxley layer. These results are consistent with the distribution of citrulline in rat HF, as observed long ago using a colorimetric reaction with Ehrlich reagent (Rogers, 1963) . No staining was observed in the ORS, sweat glands, sebaceous glands or arrector pili muscles (data not shown).
Discussion
PAD activity was first identified in the HF of the guinea-pig (Rogers and Taylor, 1977) where THH was described as a substrate for deimination. Since then, the existence of five isoforms of PAD has been reported, but their tissue distribution has yet to be explored in detail. By RT-PCR experiments, we demonstrated that PADI1, 2, and 3 are the only PADI genes expressed in skin (Nachat et al, 2005) . In order to identify the different PAD isoforms expressed in human anagen HF and other skin appendages, we performed double-label IF staining on unfixed cryosections of human scalp epidermis using our previously described anti-PAD antibodies highly specific to each of these isoforms (Guerrin et al, 2003; Nachat et al, 2005) In human anagen HF, we demonstrated the expression of PAD1, in the Huxley layer and the cuticle of the IRS and in the companion layer. We also confirmed the expression of PAD3. Indeed, PAD3 was described as the hair follicle PAD, the expression of its mRNA being very similar to that of THH in the IRS and medulla of wool follicles of sheep, as shown by in situ hybridization (Rogers et al, 1997) . In agreement, we showed that PAD3 expression, at the protein level, is restricted to the IRS and to the medulla of human anagen HF. These results somehow showed discrepancy with those obtained by Kanno et al (2000) , who reported expression not only in the IRS and medulla but also in the ORS. A likely explanation is that the treatment performed by Kanno and coworkers with sodium citrate buffer to unmask antigenic sites on fixed sections might have produced artifacts. Alternatively, the anti-PAD3 antibodies they used could have cross-reacted with another epidermal protein.
The companion layer was initially defined as the innermost layer of the ORS. Because the companion layer cells display properties different from those of the adjacent ORS cells and because their origin in the hair bulb is unrelated to that of the ORS cells, Schweizer'group proposed that the companion layer is an integral compartment of the IRS, and contributes to the guidance of hair shaft growth (Winter et al, 1998) . Our findings add a new biochemical argument to support this view: IRS and companion layer cells but not ORS cells express PAD.
The only PAD detected in the medulla and the IRS Henle layer is PAD3. Therefore, it is this isoform that is responsible for the THH deimination in these parts of the HF. In the IRS cuticle and Huxley layer, PAD1 and PAD3 are expressed simultaneously, suggesting that PAD1 may also be involved in the deimination of THH. Similarly, we previously demonstrated the co-location of PAD1, 3, and (pro)filaggrin in the granular layer and lower stratum corneum of the epidermis, and suggested that only one of the two enzymes or a combination of the two might be involved in the deimination of filaggrin (Nachat et al, 2005) . The presence of PAD1 in the cornified Huxley layer, however, suggests that deimination of THH can be completed by this isoform after cornification. PAD1 expression was also described in the superficial stratum corneum, where we proposed that it is involved in the deimination of keratin K1 (Nachat et al, 2005) . Whether K1 is also deiminated by PAD1 in the Huxley layer remains to be explored.
To study the function of THH in the HF, three MoAb allowed three distinct stages of maturation of the protein to be defined: the AE15-stained form, which is found throughout the THH granules; the AE16-stained form which is located on the surface of the granules; and the AE17-stained form, which is associated with the keratin intermediate filaments (O'Guin et al, 1992) . O'Guin et al proposed that AE16 recognizes a modified form of THH in the process of being released from the granules. Our results suggest that it is the deimination of THH by PAD3 that generates its labeling by AE16. In particular, detection of THH by AE16 coincides with the appearance of deiminated proteins. Moreover, we were able to locate PAD3 at the periphery of granules, probably THH granules, in the cytoplasm of keratinocytes in the IRS. This is in agreement with the model presented by Steinert's group, in which insoluble cytoplasmic droplets of THH that are located in the IRS and the medulla are initially modified by PAD, which converts THH to a more soluble form, and allows subsequent cross-linking by transglutaminase 3 (Tarcsa et al, 1997) .
A mouse type-I keratin, KRT1-c29, specifically expressed in the IRS cells, was shown to be deiminated before being cross-linked to THH and other cornified cell components (Steinert et al, 2003) . Our data suggest that KRT1-c29 and its human ortholog, the IRS-specific keratin 25Cirs3, are deiminated by PAD1 or 3. 
Figure 5
Expression of peptidylarginine deiminase type 1 (PAD1) and type 2 (PAD2) in arrector pili muscles. Cryosections of human scalp were analyzed by indirect immunofluorescence and confocal microscopy with anti-PAD1 (A), anti-PAD2(C 2 ) (D) and anti-a-actin (B and E) antibodies. (C and F) Image superimposition of a-actin/PAD1 and a-actin/PAD2 labeling, respectively. Scale bar ¼ 100 mm (A-C) and ¼ 75 mm (D-E).
As observed in the human epidermis, by confocal microscopy analysis (Nachat et al, 2005) , the distribution of PAD in the HF contrasts with the distribution of deiminated proteins only detected in the cornified IRS and in the medulla (Table I) (Steinert et al, 1969) . The absence of immunodetection of PAD in the cornified layers is probably due to epitope masking in these compact cell layers, which is well known to occur in the cornified layer of the epidermis. These data also suggest that PAD are activated during the final stages of terminal differentiation of the different layers of the IRS, e.g., by an increase of intracellular calcium concentration as proposed for the epidermis. Several calciumbinding proteins expressed in human HF may be involved in this control, such as THH itself (Fietz et al, 1993; Lee et al, 1993) , calcyclin (Wood et al, 1991) , CLED (Sun et al, 2000) , or proteins of the S100 family (Takizawa et al, 1999; Schmidt et al, 2001) .
We also detected PAD1 and 2 in arrector pili muscles and sweat glands, both in secretory and myoepithelial cells. PAD2 localization in sweat glands was in agreement with a previous study on human skin using a serum directed against rat-PAD2, whereas its detection in arrector pili muscles was in apparent discrepancy (Urano et al, 1990) . This could be due to experimental differences, e.g., the fixation step of cryosections with acetone used by Urano et al. Despite the expression of PAD in sweat glands and arrector pili muscles, no deiminated proteins were detected using antimodified citrulline antibodies (Table I) . Therefore, PAD may be produced as inactive forms that could be activated in particular events, like apoptosis (Asaga et al, 1998; Mizoguchi et al, 1998) or hormonal stimulation. Whether PAD expression or activation is modulated during the various phases of the HF cycle remains to be explored.
The production of anti-PAD specific antibodies allowed us to define the pattern of PAD expression in human skin appendages. The specific location of the enzymes and deiminated proteins in the IRS suggests a crucial role for deimination during terminal differentiation of HF. In particular, PAD1 and 3 may be essential for controlling mechanical resistance of the sheath due to the peripheral cell envelope and cytoplasmic keratin filament network, through THH deimination and subsequent cross-linking. Expression of peptidylarginine deiminase type 1 (PAD1) and type 2 (PAD2) in sweat glands. Cryosections of the human scalp were analyzed by indirect immunofluorescence and confocal microscopy with anti-PAD1 (A), anti-PAD2(C 2 ) (D), and anti-a-actin (B and E) antibodies. (C and F) Image superimposition of a-actin/PAD1 and a-actin/PAD2 labeling, respectively. Scale bar ¼ 75 mm.
Figure 7
Location of deiminated proteins in hair follicles (HF). Longitudinal cryosections of hair follicles were analyzed by immunoperoxidase with AMC antibodies specific to chemically modified citrullines. Note the appearance of deiminated proteins (red) first in the Henle layer (blue arrows in A and B), then in the cuticle (double-headed blue arrows in B and C) and finally in the Huxley layer (red arrows in B and C) of the inner root sheath. Deiminated proteins were also localized in the medulla (M) of the HF. Note the black pigment deposited in the hair follicles (A and B). Scale bar ¼ 100 mm.
Materials and Methods
Antibodies The MoAb G36-19 directed to CDSN was produced and characterized in our laboratory (Serre et al, 1991) . DG3.10, a MoAb directed to desmoglein 1 and 2 (DSG1 and DSG2), was purchased from Progen Biotechnik GmbH (Heidelberg, Germany). AE16, a MoAb directed to THH, was a kind gift from T. T. Sun (O'Guin et al, 1992) . Affinity-purified polyclonal antibodies directed to PAD1, 2 and 3, anti-PAD1, anti-PAD2(C 2 ), and anti-PAD3(B 3 ) were elicited in rabbits, and previously characterized (Guerrin et al, 2003; Nachat et al, 2005) . AMC, a monospecific antibody to chemically modified citrullines, was kindly given by N. Blaes, T. Senshu and has already been described (Senshu et al, 1995) . The MoAb 1A4 directed to the smooth muscle a-actin was purchased from Sigma Aldrich, St. Louis, Missouri.
Immunohistology All described studies concerning human tissues/subjects were conducted in adherence with the Declaration of Helsinki Principles, and in accordance with the ethical guidelines of the University of Toulouse III and of the French Ministry of Research and Technology. Indirect IF was performed on unfixed 5-7 mm thick cryosections of human scalp skin as previously described (Nachat et al, 2005) . In the case of double staining, the sections were further incubated with MoAb AE16, DG3.10, 1A4, or G36-19 diluted to 2.5 mg per mL. Sections were observed under a confocal laser microscope (LSM 410, Carl Zeiss, Oberkochen, Germany) , excited at 488 and 543 nm with Ar and HeNe lasers, respectively. For negative controls, sections were incubated without primary antibodies. For analyses of deiminated proteins, cryosections were incubated in 0.0125% FeCl 3 , 2.3 M H 2 SO 4 , 1.5 M H 3 PO 4 , 0.25% diacetyl monoxime, and 0.125% antipyrine (modification medium) at 371C for 3 h to modify citrulline residues chemically (Senshu et al, 1995) . Immunoperoxidase staining of the modified proteins was then performed with the AMC antibody diluted in PBS to 0.25 mg per mL for 1 h at 371C, and the Histostain-Plus kit (Zymed, San Francisco, California) using aminoethyl carbazole as a chromogenic substrate. Sections were counterstained with hematoxylin.
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